At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
nPEP (non-invasive positive expiratory pressure) maskdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-invasive Positive Expiratory Pressure Mask (PEEP-Mask) for Tracheobronchomalacia Associated Cough
In Brief
A clinical study evaluating nPEP (non-invasive positive expiratory pressure) mask for Tracheobronchomalacia. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This study aims to determine if an expiratory resistance device that delivers non-invasive positive expiratory pressure (nPEP) will reduce or stop coughing, reduce airway resistance and improve quality of life in patients with tracheobronchomalacia (TBM) who are not candidates for tracheal stenting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTracheobronchomalacia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedNov 2019
Enrollment StartAug 2021
Primary CompletionAug 2022
TodayJul 2026
First PostedNov 19, 2019
Enrollment StartAug 30, 2021
Primary CompletionAug 15, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.6 years ago
Interventions
nPEP (non-invasive positive expiratory pressure) maskdevice
Positive end expiratory pressure (PEEP) mask